JW
John Wurst
Chief Executive Officer & Co-Founder
Patent strategy expert with deep experience in intellectual property and hair-loss litigation.
About Aneira
A CLINICAL-STAGE BIOTECHNOLOGY COMPANY.
Aneira Pharma, Inc. is a clinical-stage biotechnology company developing science-driven pharmaceutical therapies for scalp and eyebrow hair growth. The company's lead programs combine established pharmacology with a differentiated dual-mechanism approach, supported by early human data and a global intellectual-property portfolio.
Leadership
EXPERIENCE ACROSS SCIENCE, IP AND DEVELOPMENT.
KA
Kenton Abel
Co-Founder; Chief Executive Officer, Object Pharma
Co-founder leading development operations through Object Pharma.
DR
Dan Radecki
Clinical Trial Advisor; President, Object Pharma
Clinical development advisor overseeing trial design and execution.
RK
Richard Kalman
Vice President & Chief Operating Officer
Manufacturing expert responsible for operations and CMC.
LD
Luis Dellamary
Formulation Advisor
Formulation scientist advising on topical combination development.
DF
Dennis Fluet
Board of Directors; Advisor to the CEO
Board member and advisor supporting corporate strategy.
Partnerships
SCIENCE TRAVELS THROUGH PARTNERSHIP.
Aneira welcomes discussions with partners across clinical development, regulatory strategy, manufacturing and CMC, geographic commercialization, distribution and strategic licensing.
Clinical developmentRegulatory strategyManufacturing / CMCGeographic commercializationDistributionStrategic licensing
Start a conversation